학술논문
Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies
Document Type
Article
Author
Source
In: Journal of Allergy and Clinical Immunology . (Journal of Allergy and Clinical Immunology, January 2023, 151(1):172-181)
Subject
Language
English
ISSN
10976825
00916749
00916749